BIOMARIN PHARMACEUTICAL INC Insider Trading for May 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for May 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 89.09 | 4,305 | 383,532 | 54,339 | 58.6 K to 54.3 K (-7.34 %) |
| May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 65,225 | |
| May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 87.34 | 5,000 | 436,700 | 115,914 | 120.9 K to 115.9 K (-4.14 %) |
| May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 88.04 | 10,000 | 880,400 | 120,914 | 130.9 K to 120.9 K (-7.64 %) |
| May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 26.49 | 15,000 | 397,350 | 130,914 | 115.9 K to 130.9 K (+12.94 %) |
| May 25 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 87.07 | 3,769 | 328,184 | 58,644 | 62.4 K to 58.6 K (-6.04 %) |
| May 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 87.05 | 5,000 | 435,249 | 130,386 | 135.4 K to 130.4 K (-3.69 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 82.71 | 1,722 | 142,427 | 62,413 | 64.1 K to 62.4 K (-2.68 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 51.26 | 202 | 10,355 | 64,135 | 63.9 K to 64.1 K (+0.32 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 82.71 | 4,932 | 407,926 | 385,224 | 390.2 K to 385.2 K (-1.26 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 82.71 | 1,096 | 90,650 | 74,444 | 75.5 K to 74.4 K (-1.45 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 82.71 | 2,036 | 168,398 | 115,914 | 118 K to 115.9 K (-1.73 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 82.71 | 1,096 | 90,650 | 61,297 | 62.4 K to 61.3 K (-1.76 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 82.71 | 1,566 | 129,524 | 135,386 | 137 K to 135.4 K (-1.14 %) |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 82.71 | 207 | 17,121 | 14,923 | 15.1 K to 14.9 K (-1.37 %) |
| May 12 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 80.80 | 679 | 54,863 | 62,393 | 63.1 K to 62.4 K (-1.08 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 80.80 | 444 | 35,875 | 15,130 | 15.6 K to 15.1 K (-2.85 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 51.26 | 327 | 16,763 | 15,574 | 15.2 K to 15.6 K (+2.14 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 80.80 | 2,088 | 168,710 | 136,952 | 139 K to 137 K (-1.50 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 51.26 | 414 | 21,223 | 139,040 | 138.6 K to 139 K (+0.30 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 80.80 | 3,131 | 252,985 | 117,950 | 121.1 K to 118 K (-2.59 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 51.26 | 415 | 21,275 | 121,081 | 120.7 K to 121.1 K (+0.34 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 86.32 | 4,658 | 402,079 | 75,540 | 80.2 K to 75.5 K (-5.81 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 84.55 | 10,000 | 845,532 | 80,198 | 90.2 K to 80.2 K (-11.09 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 80.80 | 1,696 | 137,037 | 90,198 | 91.9 K to 90.2 K (-1.85 %) |
| May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 51.26 | 414 | 21,223 | 91,894 | 91.5 K to 91.9 K (+0.45 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 20,000 | 259,800 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 20,000 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 80.80 | 5,479 | 442,703 | 390,156 | 395.6 K to 390.2 K (-1.38 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 20,000 | 1,602,978 | 0 | 20 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 20,000 | 259,800 | 20,000 | 0 to 20 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | M | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 86.03 | 415 | 35,701 | 63,072 | 63.5 K to 63.1 K (-0.65 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 51.26 | 415 | 21,275 | 63,487 | 63.1 K to 63.5 K (+0.66 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 36,500 | 474,135 | 0 | |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.01 | 36,500 | 3,102,931 | 395,635 | 432.1 K to 395.6 K (-8.45 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 36,500 | 474,135 | 432,135 | 395.6 K to 432.1 K (+9.23 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 51.26 | 414 | 21,223 | 395,635 | 395.2 K to 395.6 K (+0.10 %) |